Mutares SE & Co. KGaA

LSE:0UTK Stock Report

Market Cap: €526.3m

Mutares SE KGaA Valuation

Is 0UTK undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0UTK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0UTK (€24.2) is trading below our estimate of fair value (€200.88)

Significantly Below Fair Value: 0UTK is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0UTK?

Key metric: As 0UTK is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0UTK. This is calculated by dividing 0UTK's market cap by their current revenue.
What is 0UTK's PS Ratio?
PS Ratio0.1x
Sales€5.21b
Market Cap€526.28m

Price to Sales Ratio vs Peers

How does 0UTK's PS Ratio compare to its peers?

The above table shows the PS ratio for 0UTK vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average6.2x
POLN Pollen Street Group
4x6.2%UK£438.6m
GHE Gresham House
5.2x9.4%UK£444.6m
FSG Foresight Group Holdings
3.3x10.2%UK£480.5m
PBEE PensionBee Group
12.4x20.7%UK£350.5m
0UTK Mutares SE KGaA
0.1x10.5%€526.3m

Price-To-Sales vs Peers: 0UTK is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (5.9x).

Price to Sales Ratio vs Industry

How does 0UTK's PS Ratio compare vs other companies in the GB Capital Markets Industry?

17 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.3.2x3.6%
0UTK Mutares SE KGaA
 0.1x10.5%US$556.91m
STJ St. James's Place
0.2x-98.6%US$6.18b
QLT Quilter
0.3x-83.2%US$2.57b
0UTK 0.1xIndustry Avg. 3.2xNo. of Companies16PS03.26.49.612.816+
17 CompaniesEstimated GrowthMarket Cap
Industry Avg.3.2x18.9%
0UTK Mutares SE KGaA
 0.1x-45.5%US$556.91m
No more companies

Price-To-Sales vs Industry: 0UTK is good value based on its Price-To-Sales Ratio (0.1x) compared to the UK Capital Markets industry average (3.2x).

Price to Sales Ratio vs Fair Ratio

What is 0UTK's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0UTK PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.1x
Fair PS Ratio1.9x

Price-To-Sales vs Fair Ratio: 0UTK is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (1.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0UTK forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€24.20
€43.70
+80.6%
13.6%€50.00€36.00n/a5
Nov ’25€24.75
€43.70
+76.6%
13.6%€50.00€36.00n/a5
Oct ’25€22.15
€46.10
+108.1%
10.0%€50.00€37.00n/a5
Sep ’25€30.70
€46.10
+50.2%
10.0%€50.00€37.00n/a5
Aug ’25€31.40
€44.70
+42.4%
16.6%€50.00€30.00n/a5
Jul ’25€34.75
€44.70
+28.6%
16.6%€50.00€30.00n/a5
Jun ’25€41.80
€43.38
+3.8%
17.8%€48.00€30.00n/a4
May ’25€42.15
€40.70
-3.4%
17.8%€47.50€30.00n/a5
Apr ’25€36.28
€39.28
+8.3%
16.5%€46.40€30.00n/a5
Mar ’25€34.90
€39.28
+12.6%
16.5%€46.40€30.00n/a5
Feb ’25€37.80
€39.28
+3.9%
16.5%€46.40€30.00n/a5
Jan ’25€35.40
€38.48
+8.7%
17.1%€46.40€30.00n/a5
Dec ’24€32.82
€38.48
+17.3%
17.1%€46.40€30.00n/a5
Nov ’24€28.55
€33.60
+17.7%
8.5%€38.00€30.00€24.755
Oct ’24€27.52
€33.60
+22.1%
8.5%€38.00€30.00€22.155
Sep ’24€21.95
€33.60
+53.1%
8.5%€38.00€30.00€30.705
Aug ’24€21.68
€33.40
+54.1%
7.7%€37.00€30.00€31.405
Jul ’24€25.10
€34.00
+35.5%
7.5%€37.00€30.00€34.754
Jun ’24€23.95
€34.00
+42.0%
7.5%€37.00€30.00€41.804
May ’24€21.00
€31.00
+47.6%
15.3%€37.00€24.00€42.154
Apr ’24€19.60
€31.00
+58.2%
15.3%€37.00€24.00€36.284
Mar ’24€20.25
€31.00
+53.1%
15.3%€37.00€24.00€34.904
Feb ’24€20.55
€31.00
+50.9%
15.3%€37.00€24.00€37.804
Jan ’24€18.00
€31.00
+72.2%
15.3%€37.00€24.00€35.404
Dec ’23€18.40
€30.33
+64.9%
17.5%€37.00€24.00€32.823
Nov ’23€17.96
€30.88
+71.9%
16.0%€37.00€23.50€28.554

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

BFF Bank

€1.7b

Provides financial services to suppliers of the national health system and public administration sector in Italy, Croatia, the Czech Republic, France, Greece, Poland, Portugal, the Slovak Republic, and Spain.

0RON

€8.96

7D

0.1%

1Y

-15.2%

HAL Trust

€10.4b

Operates through multi-sectors in Europe, the United States, Canada, Asia, and internationally.

0K9V

€115.00

7D

-1.2%

1Y

1.2%

Man Group

UK£2.4b

Man Group Limited is a publicly owned investment manager.

EMGL

UK£2.10

7D

0.7%

1Y

-1.0%